Could MDMA Be A Frontline Therapeutic For Women’s Sexual Disorders? MINDCURE CEO Kelsey Ramsden Says Yes Sep 29, 2021
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory… Sep 29, 2021
PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of… Sep 28, 2021
MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted… Sep 27, 2021
Ketamine: How An Anesthetic Came To Be Used As A Psychedelic Treatment (And 5 PubCo’s Focused On It) Sep 23, 2021
